Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

The China CRO, CMO and Clinical Trial Markets

publication date: Oct 6, 2008

The CRO market in China was $186 million in 2007, according to a recent report from PricewaterhouseCoopers. That number represented growth of 38% from the year before, an increase that was mainly driven by outsourcing from international firms rather than domestic biopharmas. In the future, a CAGR estimated at 33% for the industry will bring the total China CRO market to $791 million in 2012, comprising 2.3% of the global CRO market. We report on these and other figures describing the China CRO, CMO and clinical trial markets.  More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital